cupric oxide 1.5 MG / folic acid 0.5 MG / niacinamide 750 MG / zinc oxide 25 MG Oral Tablet [Nicomide]

RxCUI
1246066
RxNorm name
cupric oxide 1.5 MG / folic acid 0.5 MG / niacinamide 750 MG / zinc oxide 25 MG Oral Tablet [Nicomide]
Display name
NICOMIDE (Oral Pill)
Full name
cupric oxide 1.5 MG / folic acid 0.5 MG / niacinamide 750 MG / zinc oxide 25 MG Oral Tablet [Nicomide]
Term type
SBD
Status
Active
Strength
1.5-0.5-750-25 mg
Dose form
Tab
Route
Oral Pill
Updated
2026-07-19 06:52:26

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
042012
Active start
042012
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
zinc oxide25 MG / 1 EACHzinc oxidezinc cation
cupric oxide1.5 MG / 1 EACHcupric oxidecupric cation
folic acid500 MCG / 1 EACHfolic acidfolic acid
niacinamide750 MG / 1 EACHniacinamideniacinamide

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
zinc oxide11423
cupric oxide21837
folic acid4511
niacinamide7405

Source Vocabulary Codes#

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 2 matching rows.

NDC11, Source, Active table
NDC11SourceActive
75854034260rxnav_ndcsyes
23589003260rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCB03BBFolic acid and derivativesATC1-4folic acid
ATCV04CXOther diagnostic agentsATC1-4folic acid
ATCA11HAOther plain vitamin preparationsATC1-4niacinamide
MEDRTD003300CopperCHEMhas_ingredientcupric oxide
MEDRTD005492Folic AcidCHEMhas_ingredientfolic acid
MEDRTD009536NiacinamideCHEMhas_ingredientniacinamide
MEDRTD015034Zinc OxideCHEMhas_ingredientzinc oxide
MEDRTD000741Anemia, AplasticDISEASEci_withfolic acid
MEDRTD018798Anemia, Iron-DeficiencyDISEASEci_withfolic acid
MEDRTD000749Anemia, MegaloblasticDISEASEmay_treatfolic acid
MEDRTD000752Anemia, PerniciousDISEASEci_withfolic acid
MEDRTD019080Cafe-au-Lait SpotsDISEASEmay_preventzinc oxide
MEDRTD003324Coronary Artery DiseaseDISEASEmay_preventniacinamide
MEDRTD003876Dermatitis, AtopicDISEASEmay_treatzinc oxide
MEDRTD003963Diaper RashDISEASEmay_treatzinc oxide
MEDRTD003967DiarrheaDISEASEinducesniacinamide
MEDRTD004342Drug HypersensitivityDISEASEci_withniacinamide
MEDRTD004342Drug HypersensitivityDISEASEci_withzinc oxide
MEDRTD004342Drug HypersensitivityDISEASEci_withfolic acid
MEDRTD004485EczemaDISEASEmay_treatzinc oxide
MEDRTD005414FlatulenceDISEASEinducesniacinamide
MEDRTD005483FlushingDISEASEinducesniacinamide
MEDRTD005494Folic Acid DeficiencyDISEASEmay_preventfolic acid
MEDRTD005494Folic Acid DeficiencyDISEASEmay_treatfolic acid
MEDRTD006470HemorrhageDISEASEci_withniacinamide
MEDRTD006937HypercholesterolemiaDISEASEmay_treatniacinamide
MEDRTD015228HypertriglyceridemiaDISEASEmay_treatniacinamide
MEDRTD007022HypotensionDISEASEci_withniacinamide
MEDRTD008107Liver DiseasesDISEASEci_withniacinamide
MEDRTD009436Neural Tube DefectsDISEASEmay_preventfolic acid
MEDRTD009750Nutritional and Metabolic DiseasesDISEASEmay_preventcupric oxide
MEDRTD009750Nutritional and Metabolic DiseasesDISEASEmay_treatcupric oxide
MEDRTD010383PellagraDISEASEmay_preventniacinamide
MEDRTD010383PellagraDISEASEmay_treatniacinamide
MEDRTD010437Peptic UlcerDISEASEci_withniacinamide
MEDRTD016491Peripheral Vascular DiseasesDISEASEmay_treatniacinamide
MEDRTD011247PregnancyDISEASEmay_preventcupric oxide
MEDRTD012878Skin NeoplasmsDISEASEmay_preventzinc oxide
MEDRTD013471SunburnDISEASEmay_preventzinc oxide
MEDRTD014947Wounds and InjuriesDISEASEmay_treatzinc oxide
MEDRTN0000000220Electrolyte ActivityMOAhas_moacupric oxide
MEDRTN0000000231Enzyme ActivatorsMOAhas_moaniacinamide
MEDRTN0000000163Enzyme InteractionsMOAhas_moafolic acid
MEDRTN0000000163Enzyme InteractionsMOAhas_moaniacinamide
MEDRTN0000000065Physiochemical ActivityMOAhas_moazinc oxide
MEDRTN0000008337Cellular Activity AlterationPEhas_pefolic acid
MEDRTN0000008337Cellular Activity AlterationPEhas_pecupric oxide
MEDRTN0000008337Cellular Activity AlterationPEhas_peniacinamide
MEDRTN0000008555Decreased Cholesterol SynthesisPEhas_peniacinamide
MEDRTN0000008687Decreased LipogenesisPEhas_peniacinamide
MEDRTN0000009061Glucose Metabolism AlterationPEhas_peniacinamide
MEDRTN0000009345Increased GlycogenolysisPEhas_peniacinamide
MEDRTN0000009399Increased Metabolic RatePEhas_peniacinamide
MEDRTN0000009739Lipid Metabolism AlterationPEhas_peniacinamide
MEDRTN0000009881Sunscreening ActivityPEhas_pezinc oxide

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH1.5 MG / 0.5 MG / 750 MG / 25 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESTTYSBD
CODESRxCUI1246066
NAMESRXNAV_STRCupric oxide 1.5 MG / folate 0.5 MG / Niacinamide 750 MG / ZNO 25 MG Oral Tablet [Nicomide]
NAMESRxNorm Namecupric oxide 1.5 MG / folic acid 0.5 MG / niacinamide 750 MG / zinc oxide 25 MG Oral Tablet [Nicomide]
NAMESRxNorm SynonymCupric oxide 1.5 MG / folate 0.5 MG / Niacinamide 750 MG / ZNO 25 MG Oral Tablet [Nicomide]
NAMESRxNorm SynonymNicomide (cupric oxide 1.5 MG / folic acid 500 MCG / niacinamide 750 MG / zinc oxide 25 MG) Oral Tablet
SOURCESSourceGold Standard Alchemy